Skip to content

Tobin W Juvenal, Chief Commercial Officer at Castle Biosciences, sold CSTL on Aug 3, 2026

Data as of Oct 16

▼ SELL$48.9K1,730 shares at $28.25Tobin W Juvenal Chief Commercial OfficerCSTL Castle Biosciences Inc
Watch CSTL
Traded
Aug 3, 2026
Disclosed
Aug 4, 2026
Filed
1 day after the trade

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

Tobin W Juvenal, Chief Commercial Officer at Castle Biosciences, sold CSTL on Aug 3, 2026TRADEDDISCLOSED
CSTLSimilar stocks (XLV — its sector index fund), rebased to CSTL's price on the disclosure day
CSTL since disclosure
+2.5%
after the sale
Similar stocks (XLV) since disclosure
+9.0%
XLV — its sector index fund

Change in closing price from Aug 4, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

Other trades in the same filing

  1. ▼ SELLTobin W Juvenal Chief Commercial OfficerCSTL Castle Biosciences Inc$235Kdisclosed Aug 4 · filed 4 days after the trade
  2. ▼ SELLTobin W Juvenal Chief Commercial OfficerCSTL Castle Biosciences Inc$57.2Kdisclosed Aug 4 · filed 4 days after the trade
  3. ▼ SELLTobin W Juvenal Chief Commercial OfficerCSTL Castle Biosciences Inc$215Kdisclosed Aug 4 · filed 4 days after the trade

See every trade on CSTL →